MARATTO

article · New England Journal of Medicine

BCG Revaccination for the Prevention of <i>Mycobacterium tuberculosis</i> Infection

202526 citationsOpen accessUniversity of Cape Town

Abstract

BCG revaccination in QFT-test negative, HIV-negative adolescents did not provide protection from sustained <i>M. tuberculosis</i> infection. (Funded by the Gates Foundation; ClinicalTrials.gov number NCT04152161.).

Research topics

  • Tuberculosis Research and Epidemiology
  • Diagnosis and treatment of tuberculosis
  • Mycobacterium research and diagnosis

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1056/nejmoa2412381

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.